NYSEARCA:IHE iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News $70.86 -0.55 (-0.77%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$70.70▼$71.8850-Day Range$65.61▼$72.8652-Week Range$55.36▼$72.94Volume29,737 shsAverage Volume67,466 shsMarket Capitalization$715.69 millionAssets Under Management$672.93 millionDividend Yield5.26%Net Expense Ratio0.40% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get iShares U.S. Pharmaceuticals ETF alerts: Email Address About iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors.Read More IHE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IHE ETF News HeadlinesAugust 15, 2024 | marketwatch.comStock Market Today: Dow rises roughly 170 points, S&P 500 edges up after July CPI inflation dataMay 23, 2024 | msn.comSEC Approves Spot Ether ETFsSeptember 8, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... April 17, 2024 | finance.yahoo.comJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in FocusApril 10, 2024 | msn.comThis weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?April 4, 2024 | msn.comUnified Action: Biden and Sanders Target Pharma PricingMarch 18, 2024 | seekingalpha.comIHI: Technological Advances Will Continue Carrying This High-Performing Medical ETFFebruary 14, 2024 | msn.comShould You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?September 8, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... February 7, 2024 | finance.yahoo.comETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings BeatSee More Headlines Receive IHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares U.S. Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IHE Inception Date5/1/2006 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason Webwww.iShares.com PhoneN/AFund Focus Asset ClassEquity BenchmarkDow Jones U.S. Select Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings40 Fund Statistics Assets Under Management$672.93 million Average Daily Volume$44,633.20 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorCitibank, N.A. AdvisorBlackRock Fund Advisors CustodianCitibank, N.A. DistributorBlackRock Investments, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableN/A Short Interest90,500 shs Miscellaneous Outstanding Shares10,100,000Beta0.58 Creation Unit50,000 Creation Fee$306.00 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << iShares U.S. Pharmaceuticals ETF ExpensesTypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.40%0.56%0.55%0.51%0.52%Other Expenses0.00%0.33%0.49%0.58%0.54%Total Expense0.40%0.71%0.71%0.74%0.71%Fee Waiver0.00%-0.45%-0.53%-0.68%-0.58%Net Expense0.40%0.61%0.61%0.58%0.59% iShares U.S. Pharmaceuticals ETF (IHE) Holdings & ExposureTop 10 IHE HoldingsJohnson & Johnson(NYSE:JNJ)Holding Weight: 23.43%Eli Lilly and Company(NYSE:LLY)Holding Weight: 22.48%Bristol-Myers Squibb(NYSE:BMY)Holding Weight: 4.86%Viatris(NASDAQ:VTRS)Holding Weight: 4.64%Pfizer(NYSE:PFE)Holding Weight: 4.31%Zoetis(NYSE:ZTS)Holding Weight: 4.31%Royalty Pharma(NASDAQ:RPRX)Holding Weight: 4.26%Catalent(NYSE:CTLT)Holding Weight: 4.16%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 3.74%Elanco Animal Health(NYSE:ELAN)Holding Weight: 2.85%IHE Sector ExposureIHE Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D. (Age 78)Independent Chairman of the Board of Trustees Michael Arthur Latham (Age 51)President, Trustee Jack Gee (Age 57)Chief Financial Officer, Treasurer Geoffrey D. FlynnChief Operating Officer, Executive Vice PresidentAmy Schioldager (Age 56)Executive Vice President Ira P. Shapiro (Age 52)Vice President, Chief Legal Officer Matt TuckerVice PresidentEilleen M. Clavere (Age 61)Secretary Cecilia H. Herbert (Age 68)Independent Trustee Charles A. Hurty (Age 73)Independent Trustee More ExecutivesSimilar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHiShares U.S. Healthcare Providers ETFNYSEARCA:IHFVanEck Biotech ETFNASDAQ:BBHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RSPHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RYHInstitutional OwnershipTruist Financial CorpSold 989 shares on 8/21/2024Ownership: 0.063%Rockport Wealth LLCBought 182,315 shares on 8/16/2024Ownership: 1.805%Marshall Wace LLPBought 6,364 shares on 8/14/2024Ownership: 0.063%Bank of Montreal CanSold 6,424 shares on 8/14/2024Ownership: 0.056%Thrivent Financial for LutheransBought 2,272 shares on 8/13/2024Ownership: 0.260%View All Institutional Transactions IHE ETF - Frequently Asked Questions How have IHE shares performed this year? iShares U.S. Pharmaceuticals ETF's stock was trading at $61.80 at the start of the year. Since then, IHE stock has increased by 14.7% and is now trading at $70.8601. View the best growth stocks for 2024 here. When did iShares U.S. Pharmaceuticals ETF's stock split? Shares of iShares U.S. Pharmaceuticals ETF split on Thursday, March 7th 2024. The 3-1 split was announced on Thursday, March 7th 2024. The newly minted shares were distributed to shareholders after the closing bell on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. Who are iShares U.S. Pharmaceuticals ETF's major shareholders? Top institutional shareholders of iShares U.S. Pharmaceuticals ETF include McElhenny Sheffield Capital Management LLC (2.83%), Aptus Capital Advisors LLC (1.82%), Rockport Wealth LLC (1.81%) and Raymond James & Associates (0.50%). How do I buy shares of iShares U.S. Pharmaceuticals ETF? Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iShares U.S. Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares U.S. Pharmaceuticals ETF investors own include United Parcel Service (UPS), CVS Health (CVS), Genuine Parts (GPC), Intel (INTC), Kinder Morgan (KMI), Wells Fargo & Company (WFC) and Archer-Daniels-Midland (ADM). This page (NYSEARCA:IHE) was last updated on 9/8/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredLast Call for Crypto Summit (RSVP FREE)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And ...Crypto 101 Media | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredExposed: 3 CENT Crypto to Explode September 23rd?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.